FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 14:49:09 2024-06-07 EDT | ||
| 8.56 EUR | +3.01% |
|
| Current month | +7.40% | ||
| 1 month | -4.36% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 8.56 | +3.01% |
| 24-06-06 | 8.31 | +2.59% |
| 24-06-05 | 8.1 | +1.89% |
| 24-06-04 | 7.95 | +1.15% |
| 24-06-03 | 7.86 | -1.38% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 02:49 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG0HJX |
| ISIN | DE000MG0HJX5 |
| Date issued | 2024-03-20 |
| Strike | 32.83 € |
| Maturity | Unlimited |
| Parity | 1.96 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.27 € |
|---|---|
| Lowest since issue | 7.53 € |
| Spread | 0.14 € |
| Spread % | 1.62% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.7
EUR
Average target price
52.64
EUR
Spread / Average Target
+5.92%
- Stock Market
- Certificates
- Certificat
